tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Income Statement

Compare
589 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q4 2025), Phathom Pharmaceuticals's total revenue was $57.58M, an increase of 94.12% from the same quarter last year. In Q4, Phathom Pharmaceuticals's net income was $-21.15M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 175.11M$ 55.25M$ 682.00K$ 0.00$ 0.00
Gross Profit
$ 152.51M$ 47.28M$ 515.00K$ -620.00K$ -521.00K
Operating Expenses
$ 312.50M$ 324.75M$ 167.83M$ 171.82M$ 134.56M
Depreciation and Amortization
$ 633.00K$ 795.00K$ 575.00K$ 620.00K$ 521.00K
EBITDA
$ -152.50M$ -261.52M$ -159.05M$ -169.80M$ -136.57M
Operating Income
$ -159.99M$ -277.47M$ -167.31M$ -172.44M$ -135.08M
Other Income/Expenses
$ -61.26M$ -56.86M$ -34.28M$ -25.28M$ -8.80M
Pretax Income
$ -221.25M$ -334.33M$ -201.59M$ -197.72M$ -143.88M
Net Income
$ -221.25M$ -334.33M$ -201.59M$ -197.72M$ -143.88M
Per Share Metrics
Basic EPS
$ -3.03$ -5.29$ -3.93$ -5.70$ -4.00
Diluted EPS
$ -3.03$ -5.29$ -3.93$ -5.70$ -4.00
Weighted Average Shares Outstanding
72.92M 63.18M 51.29M 39.12M 37.00M
Weighted Average Shares Outstanding (Diluted)
72.92M 63.18M 51.29M 39.12M 37.00M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History